LLY Posts Eli Lilly And Company

3/30/2026 12:38:59 PM

Outlook is neutral, with stock confined to a channel of ±4%

Strategy has +68% ROI potential and 11% overvalued

3/27/2026 12:58:00 PM

Outlook is neutral, with stock confined to a span of ±6%

Strategy has +56% ROI potential and 3% overvalued

3/18/2026 10:07:57 AM

Outlook is neutral, with stock confined to a span of ±4%

Strategy has +40% ROI potential and 4% overvalued

3/6/2026 3:44:08 PM

Outlook is neutral, with stock confined to a range of ±3%

Strategy has +69% ROI potential and 7% overvalued

2/23/2026 12:06:50 PM

LLY 1,055.25+45.73 (+4.5%)Eli Lilly And Company

ATM straddle for 27-Feb-26 expiration returned a positive 57.6% from the previous business day
The upside wing (25 delta calls) gained 301.2%
Downside put (25 delta puts) lost -77.2%
The company has the following event: TD Cowen's 46th Annual Health Care Conference on Mar 2, 2026.
The option volume for 27-Feb-26 expiration is 12,043
News: Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen

2/5/2026 2:27:09 PM

LLY 1,027.73-79.39 (-7.2%)Eli Lilly And Company

ATM straddle for 13-Feb-26 expiration returned a positive 65.8% from the previous business day
The upside wing (25 delta calls) declined -82.2%
Downside put (25 delta puts) gained 344.2%
The option volume for 13-Feb-26 expiration is 7,918

LLY Stock Posts